Feature Articles

Dust Hasn't Settled on Supreme Court's Gene Patent Ruling

Dust Hasn't Settled on Supreme Court's Gene Patent Ruling

Although dire predictions about the ruling on the biotech industry and health care have not come to pass, questions remain regarding the sequence-interpreting experience of the new crop of BRCA testing labs.

Attacking Cancer Cells Using Innovative Optical Technology

Attacking Cancer Cells Using Innovative Optical Technology

New optical technology is showing great promise in fighting cancer by targeting treatment but with minimal side effects to the patient.

Can Stool DNA Testing Improve CRC Screening?

Can Stool DNA Testing Improve CRC Screening?

A new study suggests that a noninvasive DNA stool test may enhance the efficacy of screening for colorectal cancer.

Excessive Uterine Leiomyosarcoma Dissemination Risk During Uterine Morcellation

Excessive Uterine Leiomyosarcoma Dissemination Risk During Uterine Morcellation

Although there are benefits to minimally invasive surgery, morcellation can increase the risk of tumor dissemination of uterine leiomyosarcomas.

Might Nano-oncology Resurrect Old Anticancer Drugs?

Might Nano-oncology Resurrect Old Anticancer Drugs?

Nanopharmaceutical formulations might allow newly widespread adoption of old anticancer agents, with reduced toxic effects.

Prostate Cancer Biomarkers: From Surveillance to Treatment Outcomes

Prostate Cancer Biomarkers: From Surveillance to Treatment Outcomes

Science presented at the 2014 Genitourinary Cancers Symposium focused on the clinical potential of prostate cancer biomarkers.

Do Mammograms Save Lives?

Do Mammograms Save Lives?

One recently published study found no mortality benefit to annual screening mammograms, but critics cry "foul."

Pre-existing Screening, Therapies May Benefit Bladder Cancer Patients

Pre-existing Screening, Therapies May Benefit Bladder Cancer Patients

HER2 screening and emetine dihydrochloride may offer patients with bladder cancer more effective treatment options.

The Renaissance of Cancer Immunotherapy

The Renaissance of Cancer Immunotherapy

The journal Science named cancer immunotherapy as "the breakthrough of the year"; but challenges still remain to overcome tumor immune suppression and genomic instability.

Treating GIST: Beyond Imatinib

Treating GIST: Beyond Imatinib

Although imatinib is the current standard of care for gastrointestinal stromal tumors, other therapies are proving to be effective treatments for the disease as well.

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs